RFK Jr. Tells House Panel Pediatric Gender Surgeries Are a ‘Condemnation to a Life of Misery’

Health and Human Services Secretary Robert F. Kennedy Jr. told members of the House Education and Workforce Committee this week that surgical gender-transition procedures performed on minors amount to a “condemnation to a life of misery.” His remarks, delivered during an oversight hearing, mark one of the most forceful public statements yet by a Cabinet official on pediatric gender medicine and signal a continued shift in federal health policy under the Trump administration.

Kennedy, who was confirmed as the nation’s top health official in February 2025, used the hearing to defend the administration’s broader posture on pediatric gender medicine, arguing that irreversible surgical interventions carry consequences that children are not developmentally equipped to weigh. His testimony aligns with Executive Order 14187, issued by President Donald Trump on January 28, 2025, which directed federal agencies to stop funding or facilitating what the order described as “chemical and surgical mutilation” of minors. In the months since, the Department of Health and Human Services, the Centers for Medicare and Medicaid Services, and the Department of Veterans Affairs have each moved to tighten or rescind coverage pathways for gender-affirming procedures for individuals under 19.

The policy debate occurs against a rapidly evolving international landscape. The United Kingdom’s National Health Service closed the Tavistock gender identity clinic in 2024 following the Cass Review, an independent inquiry that found the evidence underpinning pediatric gender medicine to be “remarkably weak.” Sweden, Finland, Norway, and Denmark have each imposed significant restrictions on puberty blockers and cross-sex hormones for minors outside research settings. In the United States, more than two dozen states have enacted laws restricting such treatments for those under 18, while medical associations including the American Academy of Pediatrics and the Endocrine Society continue to endorse a gender-affirming care model, citing risks of depression and suicidality when access is denied. Estimates from the UCLA Williams Institute suggest roughly 300,000 U.S. adolescents aged 13 to 17 identify as transgender, though the share who undergo surgical procedures before adulthood is considerably smaller.

The next phase of the policy fight is likely to play out in the courts and in state legislatures. Following the Supreme Court’s 6-3 ruling in United States v. Skrmetti, which upheld Tennessee’s restrictions under rational-basis review, lower courts are reevaluating injunctions that had blocked similar laws in other states. Congressional Democrats have signaled intent to introduce legislation protecting access to gender-affirming care, while Republican lawmakers are pursuing federal statutory codification of the administration’s restrictions. Observers should also watch for forthcoming HHS guidance on Medicaid coverage rules and potential Title IX rulemaking that could further shape how schools and hospitals respond.